STOCK TITAN
  1. Home
  2. Financials
  3. BRTX
  4. Revenue

BioRestorative Therapies, Inc. (BRTX) Revenue by Year

BRTX

BioRestorative Therapies, Inc. generated $360K in revenue in fiscal year 2025. This represents a decrease of 10.3% from the prior fiscal year. Over the trailing 12 months, Q2 FY2025 through Q1 FY2026, the same line adds up to $358K in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters BioRestorative Therapies, Inc. has filed alongside them.

FY2025 annual
Revenue $360K
YoY -10.3%
5Y CAGR +36.1%
10Y CAGR -5.4%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

BRTX Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Revenue$358K$360K-10.3%$401K+175.0%$146K+21.7%$120K+160.4%$46K-40.3%$77K-40.8%$130K+17.1%$111K+37.0%$81K+122.8%$36K-94.2%$629K+51.2%$416K+24661.7%$2K-89.2%$16K$0

TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.

BRTX Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-Q
Revenue$23K-7.3%$20K-54.7%$12K-94.9%$303K+240.4%$25K-28.6%$43K+124.4%$234K+660.9%$89K+38.1%$35K+11.8%$19K+421.6%$31K+5.9%$65K-9.3%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More BioRestorative Therapies, Inc. financials

Frequently Asked Questions

What was BioRestorative Therapies, Inc.'s revenue in fiscal year 2025?

BioRestorative Therapies, Inc. generated $360K in revenue in fiscal year 2025.

How fast is BioRestorative Therapies, Inc.'s revenue growing?

BioRestorative Therapies, Inc. (BRTX) revenue fell by 10.3% year over year, from $401K to $360K in fiscal year 2025.

What is BioRestorative Therapies, Inc.'s revenue over the last twelve months?

BioRestorative Therapies, Inc. (BRTX) reported $358K in revenue over the trailing 12 months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, BioRestorative Therapies, Inc. (BRTX) revenue went from $0 in fiscal year 2011 to $360K in fiscal year 2025.

BioRestorative Therapies, Inc. (BRTX) reported $23K in revenue in Q1 2026. This represents a decrease of 7.3% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what BioRestorative Therapies, Inc. (BRTX) reported on that line in every period on record.